Synlett 2020; 31(01): 69-72
DOI: 10.1055/s-0039-1691503
letter
© Georg Thieme Verlag Stuttgart · New York

First Total Synthesis of Jomthonic Acid A[1]

Mohan Dumpala
,
Batthula Srinivas
,
D-211, Discovery Laboratory, Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad-500 007, India   Email: prkgenius@iict.res.in
› Author Affiliations
Further Information

Publication History

Received: 14 October 2019

Accepted after revision: 07 November 2019

Publication Date:
29 November 2019 (online)

 


Abstract

A stereoselective total synthesis of jomthonic acid A is described. The key features of the synthetic strategy are a Sharpless asymmetric epoxidation, a Gilmann reagent-induced methylation, a Mitsunobu reaction, a Yamaguchi esterification, and an O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TBTU)-mediated amide coupling. Jomthonic acid A is an architecturally rare amino acid containing a β-methylphenylalanine residue and a 4-methyl-(2E,4E)-hexa-2,4-dienoate moiety. It shows antidiabetic and antiatherogenic activities when tested against mouse ST-13 preadiopocytes.


#

Actinomycetes are a major source of structurally diverse secondary metabolites that exhibit antagonism to Gram-positive bacteria. Igarashi and co-workers recently reported the isolation and characterization of the modified amino acid derivative jomthonic acid A (1; Figure [1]) from the culture broth of a soil-derived actinomycete of the genus Streptomyces sp. BB47.[2] Compound 1 contains four stereocenters and several unusual structural features, such as the 4-methyl-(2E,4E)-hexa-2,4-dienoate and β-methylphenylalanine fragments. Jomthonic acid A exhibits antidiabetic and antiatherogenic activities against mouse ST-13 preadiopocytes and it also inhibits the differentiation of preadipocytes into mature adipocytes at 2–50 μM.

Zoom Image
Figure 1

In continuation of our interest in the total synthesis of bioactive natural products,[3] we have developed a convergent synthesis of jomthonic acid A (1). Our retrosynthetic analysis of 1 (Scheme [1]) suggested that it might be derived from the amido ester 2 through deprotection followed by oxidation. Compound 2 might be prepared from 4-methylhexa-2,4-dienoic acid (3) and amino ester 4 through amide coupling.[4] Compound 4 might be assembled from azide 5 and alcohol 6 under Yamaguchi conditions.[5] Compound 5 might, in turn, be obtained from trans-cinnamyl alcohol (7) by epoxidation, regioselective ring opening of the epoxide with the Gilmann reagent, and Mitsunobu reaction followed by oxidation. Likewise, alcohol 6 might be obtained by Frater–Seebach alkylation of ethyl (3R)-3-hydroxybutanoate.[6]

Zoom Image
Scheme 1 Retrosynthetic analysis of jomthonic acid A (1)

Our synthetic approach began with commercially available trans-cinnamyl alcohol (7; Scheme [2]). This was converted into the chiral epoxy alcohol 9 in 87% yield by Sharpless asymmetric epoxidation. Regioselective ring opening of epoxide 9 with the Gilmann reagent gave diol 10 in 68% yield.[7] Next, selective protection of the primary hydroxy group of 1,2-diol 10 by TBDMSCl/imidazole/Bu2SnO in ­CH2Cl2 at 0 °C for two hours gave silyl ether 11 in 93% yield. Subsequently, 11 was converted into the corresponding azide 12 in 85% yield under Mitsunobu conditions by using diphenyl phosphorazidate (DPPA) and DIAD in anhydrous THF at 0 °C to room temperature.[8] [9] Subsequent deprotection of silyl ether 12 with TBAF in THF afforded alcohol 13 (95% yield).[10] The purity of compound 13 was determined by LC/MS analysis, and the diastereomeric excess was found to be 98% (see Supporting Information). Compound 13, on further oxidation with TEMPO and PhI(OAc)2 in CH2Cl2–H2O (4:1) gave acid 5 in 93% yield.[11]

Zoom Image
Scheme 2 Synthesis of fragment 5

In parallel, compound 6, required for the Yamaguchi esterification, was prepared from commercially available ethyl (3R)-3-hydroxybutanoate (8; Scheme [3]). Frater–Seebach alkylation of 8 gave 1,3-diol 14.[6] [12] Selective protection of the primary hydroxy group of this 1,3-diol with TBDPSCl/imidazole/Bu2SnO in CH2Cl2 at 0 °C to room temperature gave silyl ether 6 in 93% yield.

Zoom Image
Scheme 3 Synthesis of fragment 6

Having both coupling partners in hand, we performed a Yamaguchi esterification of acid 5 with silyl ether 6 to give the azide derivative 15 in 68% yield (Scheme [4]).[5] [13] Reduction of azide 15 with H2 (1 atm) over Pd/C gave amine 4 in 90% yield. Compound 2 was obtained in 68% yield by O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TBTU)-mediated coupling of amine 4 with acid 3, prepared from tiglic aldehyde by a reported procedure.[4] [14] Subsequently, the silyl group was removed by treatment with HF·Py in CH3CN at 0 °C to room temperature to afford the alcohol 16 in 85% yield.[15] Finally oxidation of 16 with TEMPO and PhI(OAc)2 in CH2Cl2–H2O (4:1) gave the target compound 1. Spectroscopic data for this product were consistent with the reported values.[2]

Zoom Image
Scheme 4 Synthesis of jomthonic acid A (1)

In conclusion, the first stereoselective total synthesis of jomthonic acid A was achieved by a convergent approach with an 8.0% overall yield by employing a Sharpless asymmetric epoxidation, a Gilmann reaction, a Mitsunobu azidation, hydrogenation, a Yamaguchi esterification, and amide coupling as the key steps.


#

Acknowledgment

M.D. and B.S are grateful to the UGC, New Delhi for the financial support in the form of fellowships.

Supporting Information

  • References and Notes

  • 1 Communication No. IICT/Pubs./2019/237.
    • 2a Igarashi Y, Yu L, Ikeda M, Oikawa T, Kitani S, Nihira T, Bayanmunkh B, Panbangred W. J. Nat. Prod. 2012; 75: 986
    • 2b García-Salcedo R, Álvarez-Álvarez R, Olano C, Cañedo L, Braña AF, Méndez C, De la Calle F, Salas JA. Mar. Drugs 2018; 16: 259
    • 2c Yu L, Oikawa T, Kitani S, Nihira T, Bayanmunkh B, Panbangred W, Igarashi Y. J. Antibiot. 2014; 67: 345
  • 3 Bérdy J. J. Antibiot. 2012; 65: 385
  • 4 Markworth CJ, Marron BE, Swain NA. WO 2010035166, 2010
  • 5 Dhimitruka I, SantaLucia J. Org. Lett. 2006; 8: 47
  • 6 Fráter G, Müller U, Günther W. Tetrahedron 1984; 40: 1269
    • 7a Radha Krishna P, Arun Kumar PV, Mallula VS, Ramakrishna KV. S. Tetrahedron 2013; 69: 2319
    • 7b Simmons B, Walji AM, MacMillan DW. C. Angew. Chem. Int. Ed. 2009; 48: 4349
  • 9 {[(2S,3R)-2-Azido-3-phenylbutyl]oxy}(tert-butyl)dimethyl­silane (12)To a solution of compound 11 (1.7 g, 6.0 mmol) in THF (20 mL) at 0 °C were added DIAD (2.39 mL, 12.1 mmol) and TPP (3.1 g, 12.1 mmol), and the mixture was stirred for 5 min. DPPA (2.61 g, 9.5 mmol) was added at 0 °C, and the mixture was allowed to warm to rt, stirred for 3 h, then warmed to 35 °C for 24 h. The mixture was then concentrated and purified by flash column chromatography [silica gel, EtOAc–hexane (8:92)] to give a pale-yellow oil; yield: 1.48 g (80%).1H NMR (400 MHz, CDCl3): δ = 7.33–7.26 (m, 2 H), 7.24–7.16 (m, 3 H), 3.60 (dd, J = 10.4, 3.1 Hz, 1 H), 3.4–3.40 (m, 1 H), 3.39–3.33 (m, 1 H), 2.91 (dq, J = 14.1, 7.0 Hz, 1 H). 1.35 (d, J = 7.0 Hz, 3 H), 0.88 (s, 9 H), –0.02 (s, 6 H). 13C NMR (100 MHz, CDCl3): δ = 143.5, 128.6, 127.55, 126.5, 69.2, 64.9, 40.3, 25.8, 18.4, 18.2, –5.6. EI-ESI: m/z = 323 [M + NH4]+.
  • 10 (2S,3R)-2-Azido-3-phenylbutan-1-ol (13)A 1.0 M solution of TBAF in THF (1.54 g, 8.85 mL, 5.9 mmol) was added to a solution of compound 12 (1.2 g, 3.9 mmol) in anhyd THF (10 mL) at 0 °C, and the mixture was stirred at rt for 2 h. When the reaction was complete, the mixture was diluted with H2O (5 mL), and the mixture was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (2 x 10 mL) and dried (Na2SO4). Filtration, and evaporation of the solvent under reduced pressure, followed by column chromatography [silica gel, EtOAc–hexane (20:80)] gave a colorless liquid; yield: 0.676 g (90%); [α]D 25 –9.1 (c 0.7, CHCl3).1H NMR (400 MHz, CDCl3): δ = 7.37–7.30 (m, 2 H), 7.27–7.19 (m, 3 H), 3.60–3.50 (m, 2 H), 3.46–3.37 (m, 1 H), 2.94–2.83 (m, 1 H), 1.40 (d, J = 6.9 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 142.8, 128.7, 127.3, 127.0, 70.3, 64.0, 41.4, 18.4. EI-ESI: m/z = 209 [M + NH4]+.
  • 11 Zhao M, Li J, Song Z, Desmond R, Tschaen DM, Grabowski EJ. J, Reider PJ. Tetrahedron Lett. 1998; 39: 5323
  • 13 (1R,2S)-3-{[tert-Butyl(diphenyl)silyl]oxy}-1,2-dimethyl­propyl (2S,3R)-2-Azido-3-phenylbutanoate (15)To a stirred solution of azide 5 (0.200 g, 0.9 mmol), alcohol 6 (0.333 g, 0.9 mmol), and Et3N (0.4 mL, 2.9 mmol) in THF (5 mL) was added 2,4,6-trichlorobenzoyl chloride (0.2 mL, 1.1 mmol) at rt, and the mixture was stirred for 2 h. DMAP (0.238 g, 1.6 mmol) was added at rt, and the mixture was stirred for 6 h. When the reaction was complete, the mixture was quenched with sat. aq NaHCO3 and washed with brine. The organic layer was dried (Na2SO4), filtered, and concentrated in vacuo. The residue was purified by column chromatography [silica gel, EtOAc–hexane (20:80)] to give a colorless oil; yield: 0.349 g, (68%); [α]D 25 +22.0 (c 0.5, CHCl3).1H NMR (500 MHz, CDCl3): δ = 7.67–7.62 (m, 4 H), 7.45–7.35 (m, 6 H), 7.25–7.17 (m, 5 H), 5.02–4.95 (m, 1 H), 3.80 (dd, J = 7.2, 14.9 Hz, 1 H), 3.56–3.40 (m, 2 H), 3.28–3.20 (m, 1 H), 1.93–1.74 (m, 1 H), 1.34 (d, J = 7.0 Hz, 3 H), 1.05 (d, J = 5.1 Hz, 3 H), 1.04 (s, 9 H), 0.87 (d, J = 6.4 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 169.1, 141.4, 135.5, 129.6, 128.5, 127.7, 127.6, 127.2, 73.6, 67.6, 65.1, 41.7, 39.9, 26.8, 19.2, 17.0, 15.7, 12.3. HRMS (ESI): m/z [M + NH4]+ calcd for C31H43N4O3Si: 547.3104; found: 547.3104.
  • 14 Matsumoto A, Sada K, Tashiro K, Miyata M, Tsubouchi T, Tanaka T, Odani T, Nagahama S, Tanaka T, Inoue K, Saragai S, Nakamoto S. Angew. Chem. Int. Ed. 2002; 41: 2502
  • 15 (1R,2S)-3-Hydroxy-1,2-dimethylpropyl (βR)-β-Methyl-N-[(2E,4E)-4-methylhexa-2,4-dienoyl]-l-phenylalaninate (16)HF·pyridine (0.09 mL) was added dropwise to a stirred solution of 2 (0.070 g, 0.1 mmol) in anhyd CH3CN (2 mL) at 0 °C, and the mixture was stirred for 12 h. The reaction was then quenched by adding sat. aq NaHCO3 (1 mL) and the mixture was extracted with EtOAc (3 × 5 mL). The organic extracts were washed with brine (5 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The residue was purified by column chromatography [silica gel, EtOAc–hexane (25:75)] to give a pale-yellow liquid; yield: 0.030 g (85%); [α]D 25 +20.33 (c 0.3, CHCl3).1H NMR (500 MHz, CDCl3): δ = 7.33–7.23 (m, 5 H), 7.23 (d, J = 7.0 Hz, 1 H), 5.95 (q, J = 7.0 Hz, 1 H), 6.15–6.10 (m, 1 H), 5.77 (d, J = 15.2 Hz, 1 H), 4.82–4.70 (m, 2 H), 3.54 (dd, J = 7.0, 11.4 Hz, 1 H), 3.40 (dd, J = 6.7, 11.4 Hz, 1 H), 3.26–3.20 (m, 1 H), 3.13 (dq, J = 7.4, 7.7 Hz, 1 H), 1.86–1.80 (m, 1 H), 1.80 (d, J = 7.0 Hz, 3 H), 1.76 (s, 3 H), 1.40 (d, J = 7.1 Hz, 3 H), 0.87 (d, J = 7.0 Hz, 3 H), 0.78 (d, J = 6.4 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 172.0, 166.7, 146.9, 141.2, 135.6, 133.3, 128.4, 127.9, 127.2, 116.6, 73.6, 64.2, 58.2, 43.0, 40.4, 18.1, 16.8, 14.4, 13.2, 11.8. HRMS (ESI): m/z [M + H]+ calcd for C22H32NO4: 374.2331; found: 374.2328.

  • References and Notes

  • 1 Communication No. IICT/Pubs./2019/237.
    • 2a Igarashi Y, Yu L, Ikeda M, Oikawa T, Kitani S, Nihira T, Bayanmunkh B, Panbangred W. J. Nat. Prod. 2012; 75: 986
    • 2b García-Salcedo R, Álvarez-Álvarez R, Olano C, Cañedo L, Braña AF, Méndez C, De la Calle F, Salas JA. Mar. Drugs 2018; 16: 259
    • 2c Yu L, Oikawa T, Kitani S, Nihira T, Bayanmunkh B, Panbangred W, Igarashi Y. J. Antibiot. 2014; 67: 345
  • 3 Bérdy J. J. Antibiot. 2012; 65: 385
  • 4 Markworth CJ, Marron BE, Swain NA. WO 2010035166, 2010
  • 5 Dhimitruka I, SantaLucia J. Org. Lett. 2006; 8: 47
  • 6 Fráter G, Müller U, Günther W. Tetrahedron 1984; 40: 1269
    • 7a Radha Krishna P, Arun Kumar PV, Mallula VS, Ramakrishna KV. S. Tetrahedron 2013; 69: 2319
    • 7b Simmons B, Walji AM, MacMillan DW. C. Angew. Chem. Int. Ed. 2009; 48: 4349
  • 9 {[(2S,3R)-2-Azido-3-phenylbutyl]oxy}(tert-butyl)dimethyl­silane (12)To a solution of compound 11 (1.7 g, 6.0 mmol) in THF (20 mL) at 0 °C were added DIAD (2.39 mL, 12.1 mmol) and TPP (3.1 g, 12.1 mmol), and the mixture was stirred for 5 min. DPPA (2.61 g, 9.5 mmol) was added at 0 °C, and the mixture was allowed to warm to rt, stirred for 3 h, then warmed to 35 °C for 24 h. The mixture was then concentrated and purified by flash column chromatography [silica gel, EtOAc–hexane (8:92)] to give a pale-yellow oil; yield: 1.48 g (80%).1H NMR (400 MHz, CDCl3): δ = 7.33–7.26 (m, 2 H), 7.24–7.16 (m, 3 H), 3.60 (dd, J = 10.4, 3.1 Hz, 1 H), 3.4–3.40 (m, 1 H), 3.39–3.33 (m, 1 H), 2.91 (dq, J = 14.1, 7.0 Hz, 1 H). 1.35 (d, J = 7.0 Hz, 3 H), 0.88 (s, 9 H), –0.02 (s, 6 H). 13C NMR (100 MHz, CDCl3): δ = 143.5, 128.6, 127.55, 126.5, 69.2, 64.9, 40.3, 25.8, 18.4, 18.2, –5.6. EI-ESI: m/z = 323 [M + NH4]+.
  • 10 (2S,3R)-2-Azido-3-phenylbutan-1-ol (13)A 1.0 M solution of TBAF in THF (1.54 g, 8.85 mL, 5.9 mmol) was added to a solution of compound 12 (1.2 g, 3.9 mmol) in anhyd THF (10 mL) at 0 °C, and the mixture was stirred at rt for 2 h. When the reaction was complete, the mixture was diluted with H2O (5 mL), and the mixture was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (2 x 10 mL) and dried (Na2SO4). Filtration, and evaporation of the solvent under reduced pressure, followed by column chromatography [silica gel, EtOAc–hexane (20:80)] gave a colorless liquid; yield: 0.676 g (90%); [α]D 25 –9.1 (c 0.7, CHCl3).1H NMR (400 MHz, CDCl3): δ = 7.37–7.30 (m, 2 H), 7.27–7.19 (m, 3 H), 3.60–3.50 (m, 2 H), 3.46–3.37 (m, 1 H), 2.94–2.83 (m, 1 H), 1.40 (d, J = 6.9 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 142.8, 128.7, 127.3, 127.0, 70.3, 64.0, 41.4, 18.4. EI-ESI: m/z = 209 [M + NH4]+.
  • 11 Zhao M, Li J, Song Z, Desmond R, Tschaen DM, Grabowski EJ. J, Reider PJ. Tetrahedron Lett. 1998; 39: 5323
  • 13 (1R,2S)-3-{[tert-Butyl(diphenyl)silyl]oxy}-1,2-dimethyl­propyl (2S,3R)-2-Azido-3-phenylbutanoate (15)To a stirred solution of azide 5 (0.200 g, 0.9 mmol), alcohol 6 (0.333 g, 0.9 mmol), and Et3N (0.4 mL, 2.9 mmol) in THF (5 mL) was added 2,4,6-trichlorobenzoyl chloride (0.2 mL, 1.1 mmol) at rt, and the mixture was stirred for 2 h. DMAP (0.238 g, 1.6 mmol) was added at rt, and the mixture was stirred for 6 h. When the reaction was complete, the mixture was quenched with sat. aq NaHCO3 and washed with brine. The organic layer was dried (Na2SO4), filtered, and concentrated in vacuo. The residue was purified by column chromatography [silica gel, EtOAc–hexane (20:80)] to give a colorless oil; yield: 0.349 g, (68%); [α]D 25 +22.0 (c 0.5, CHCl3).1H NMR (500 MHz, CDCl3): δ = 7.67–7.62 (m, 4 H), 7.45–7.35 (m, 6 H), 7.25–7.17 (m, 5 H), 5.02–4.95 (m, 1 H), 3.80 (dd, J = 7.2, 14.9 Hz, 1 H), 3.56–3.40 (m, 2 H), 3.28–3.20 (m, 1 H), 1.93–1.74 (m, 1 H), 1.34 (d, J = 7.0 Hz, 3 H), 1.05 (d, J = 5.1 Hz, 3 H), 1.04 (s, 9 H), 0.87 (d, J = 6.4 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 169.1, 141.4, 135.5, 129.6, 128.5, 127.7, 127.6, 127.2, 73.6, 67.6, 65.1, 41.7, 39.9, 26.8, 19.2, 17.0, 15.7, 12.3. HRMS (ESI): m/z [M + NH4]+ calcd for C31H43N4O3Si: 547.3104; found: 547.3104.
  • 14 Matsumoto A, Sada K, Tashiro K, Miyata M, Tsubouchi T, Tanaka T, Odani T, Nagahama S, Tanaka T, Inoue K, Saragai S, Nakamoto S. Angew. Chem. Int. Ed. 2002; 41: 2502
  • 15 (1R,2S)-3-Hydroxy-1,2-dimethylpropyl (βR)-β-Methyl-N-[(2E,4E)-4-methylhexa-2,4-dienoyl]-l-phenylalaninate (16)HF·pyridine (0.09 mL) was added dropwise to a stirred solution of 2 (0.070 g, 0.1 mmol) in anhyd CH3CN (2 mL) at 0 °C, and the mixture was stirred for 12 h. The reaction was then quenched by adding sat. aq NaHCO3 (1 mL) and the mixture was extracted with EtOAc (3 × 5 mL). The organic extracts were washed with brine (5 mL), dried (Na2SO4), filtered, and concentrated in vacuo. The residue was purified by column chromatography [silica gel, EtOAc–hexane (25:75)] to give a pale-yellow liquid; yield: 0.030 g (85%); [α]D 25 +20.33 (c 0.3, CHCl3).1H NMR (500 MHz, CDCl3): δ = 7.33–7.23 (m, 5 H), 7.23 (d, J = 7.0 Hz, 1 H), 5.95 (q, J = 7.0 Hz, 1 H), 6.15–6.10 (m, 1 H), 5.77 (d, J = 15.2 Hz, 1 H), 4.82–4.70 (m, 2 H), 3.54 (dd, J = 7.0, 11.4 Hz, 1 H), 3.40 (dd, J = 6.7, 11.4 Hz, 1 H), 3.26–3.20 (m, 1 H), 3.13 (dq, J = 7.4, 7.7 Hz, 1 H), 1.86–1.80 (m, 1 H), 1.80 (d, J = 7.0 Hz, 3 H), 1.76 (s, 3 H), 1.40 (d, J = 7.1 Hz, 3 H), 0.87 (d, J = 7.0 Hz, 3 H), 0.78 (d, J = 6.4 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 172.0, 166.7, 146.9, 141.2, 135.6, 133.3, 128.4, 127.9, 127.2, 116.6, 73.6, 64.2, 58.2, 43.0, 40.4, 18.1, 16.8, 14.4, 13.2, 11.8. HRMS (ESI): m/z [M + H]+ calcd for C22H32NO4: 374.2331; found: 374.2328.

Zoom Image
Figure 1
Zoom Image
Scheme 1 Retrosynthetic analysis of jomthonic acid A (1)
Zoom Image
Scheme 2 Synthesis of fragment 5
Zoom Image
Scheme 3 Synthesis of fragment 6
Zoom Image
Scheme 4 Synthesis of jomthonic acid A (1)